Spherix Global Insights

On February 12, the FDA accepted its first new drug application for a hypoxia-inducible factor prolyl hydroxylase inhibitor. The agency has set a Prescription Drug User Fee Act date of Dec. 20, 2020 for final review and approval.

BOSTON — Compared to other medical specialists, nephrologists indicated less opportunity for innovation in their specialty, according to results of a cross-comparison study presented here at the National Kidney Foundation Spring Clinical Meetings.